中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Pharmacokinetics of telmisartan in healthy chinese subjects after oral administration of two dosage levels

文献类型:期刊论文

作者Zhang, Peng; Zhang, Yifan; Chen, Xiaoyan; Li, Rongqin; Yin, Jian; Zhong, Dafang
刊名ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
出版日期2006
卷号56期号:8页码:569-573
关键词angiotensin II receptor antagonist antihypertensive agent CAS 144701-48-4 MicardisPlus((R)) Telmisartan, clinical pharmacoldnetics, dose-related analysis
ISSN号0004-4172
文献子类Article
英文摘要To study the pharmacokinetics of telmisartan in healthy Chinese male subjects after oral administration of two dosage levels, 36 healthy subjects were divided into two groups and given a single oral dose of 40 or 80 mg telmisartan (CAS 144701-48-4, MicardisPlus((R))). A sensitive liquid chromatography-tandem mass spectrometry method (LC-MS-MS) was used for the determination of telmisartan in plasma. Both, a non-compartmental and compartmental method were used for analysis of parameters of kinetics. The main pharmacokinetic parameters of the 40 mg and 80 mg regimen group were as follows: t(max) (1.76 +/- 1.75) h, (1.56 +/- 1.09) h, C-max (163.2 +/- 128.4) ng/mL, (905.7 +/- 583.4) ng/mL, t(1/2) (23.6 +/- 10.8) h, (23.0 +/- 6.4) h, AUC(0-t) (1456 +/- 1072) ng(.)h/mL, (6759 +/- 3754) ng(.)h/mL, AUC(0-infinity) (1611 +/- 1180) ng(.)h/mL, (7588 +/- 4661) ng(.)h/mL, respectively. After dose normalization, there was significant difference for main pharmacokinetic parameters C-max, AUC(0-t) and AUC(0-infinity). between two dosage level groups. The plasma concentration-time profile of telmisartan was characterized by a high degree of inter-individual variability and the disposition of telmisartan in healthy Chinese subjects was dose-dependent. The pharmacokinetic parameters C-max and AUC(0-infinity) of the 80 mg regimen group increased to about 5-fold compared to that of the 40 mg regimen group, but there was no significant difference for t(max) and t(1/2) between the two dose groups.
WOS关键词RAPID-DETERMINATION ; SERUM
WOS研究方向Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000240760500001
出版者ECV-EDITIO CANTOR VERLAG MEDIZIN NATURWISSENSCHAFTEN
源URL[http://119.78.100.183/handle/2S10ELR8/273695]  
专题上海药物代谢研究中心
通讯作者Zhong, Dafang
作者单位1.Shenyang Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Shenyang, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
3.Peoples Hosp Liaoning Prov, Shenyang, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Peng,Zhang, Yifan,Chen, Xiaoyan,et al. Pharmacokinetics of telmisartan in healthy chinese subjects after oral administration of two dosage levels[J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH,2006,56(8):569-573.
APA Zhang, Peng,Zhang, Yifan,Chen, Xiaoyan,Li, Rongqin,Yin, Jian,&Zhong, Dafang.(2006).Pharmacokinetics of telmisartan in healthy chinese subjects after oral administration of two dosage levels.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH,56(8),569-573.
MLA Zhang, Peng,et al."Pharmacokinetics of telmisartan in healthy chinese subjects after oral administration of two dosage levels".ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 56.8(2006):569-573.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。